Skeletal Muscle Channelopathies

Skeletal muscle channelopathies generally share common symptoms, such as paroxysmal episodes, while also presenting distinct clinical features for each subtype.

Common Manifestations

• Myotonia: Defined as delayed muscle relaxation; it typically presents as difficulty releasing a grip (hand-opening) or opening the eyes after forceful closure.

• Triggers: Cold exposure and the initiation of movement are the primary factors that worsen myotonia.

• Malignant Hyperthermia (MH): A potentially fatal medical emergency (most often associated with CACNA1S mutations) triggered by “volatile” anesthetic agents during general anesthesia.

• Consciousness: Always preserved during paralytic episodes.

• Respiratory Function: Respiratory muscles, including the diaphragm, are generally spared throughout the course of the disease.

• Interictal Phase: Muscle function is typically preserved between episodes.

Periodic Paralyses (SCN4A, CACNA1S, KCNJ2)

1. Hypokalemic Periodic Paralysis (HypoPP):

• Paralysis: Episodes last for hours or days; weakness is typically symmetrical and proximal. Severity ranges from mild weakness to complete paralysis.

• Triggers: High-carbohydrate meals, rest after exercise, stress, and cold.

• Potassium Levels: Serum potassium decreases (hypokalemia) during attacks and normalizes between episodes.

• Onset: Childhood or adolescence.

2. Hyperkalemic Periodic Paralysis (HyperPP):

• Paralysis: Shorter episodes lasting minutes to hours.

• Triggers: Potassium-rich foods, fasting, and rest after light exercise.

• Potassium Levels: Usually normal or elevated during attacks.

• Associated Myotonia: Frequent; typically improves with movement.

• Onset: Early childhood.

3. Andersen-Tawil Syndrome (KCNJ2):

• Clinical Triad: Periodic paralysis + cardiac arrhythmias + dysmorphic features.

• Cardiac Features: Long QT syndrome, ventricular arrhythmias, and extrasystoles.

• Dysmorphic Features: Short stature, scoliosis, clinodactyly, and hypertelorism.

Myotonia Congenita (CLCN1)

1. Thomsen Disease (Autosomal Dominant):

• Myotonia: Onset usually in early childhood; distribution is typically generalized and symmetrical.

• Warm-up Phenomenon: Myotonic stiffness improves with repeated muscle contraction.

• Muscle Hypertrophy: Patients often exhibit a diffuse increase in muscle mass, resulting in a characteristic “herculean” appearance.

2. Becker Disease (Autosomal Recessive):

• Myotonia: Generally more severe than the Thomsen form; frequently affects the legs and is often accompanied by episodes of transient muscle weakness.

• Onset: Early childhood or adolescence; this is the more common form of myotonia congenita.

The diagnostic workflow for muscle channelopathies requires an integrated approach combining clinical history, specialized electrophysiology, and advanced genetic testing.

Clinical and Neurological Assessment

• Clinical History: Detailed anamnesis of episodes (duration, frequency, and triggers), family history (assessment for autosomal dominant patterns), response to previous treatments, and anesthetic history (to identify Malignant Hyperthermia risks).

• Physical Examination: * During an episode: Assessment of muscle strength, diminished reflexes, and confirmation of normal sensation.

  • Interictal period: Typically normal findings.

  • Myotonia testing: Forceful muscle contraction (action myotonia) and percussion of the muscle bellies (percussion myotonia).

Specialized Electrophysiology and Laboratory Tests

• Specialized EMG: * During paralysis: Electrical silence in the muscle.

  • Myotonia: Presence of characteristic myotonic discharges.

  • Cooling Test: Evaluation of worsening myotonia upon local exposure to cold.

• Provocative Testing: Controlled hospital-based tests such as the Long Exercise Test (looking for a >40% decline in amplitude), glucose-insulin challenges (for HypoPP), or potassium challenges (for HyperPP).

• Laboratory Work: Electrolyte levels ($K^+$, $Na^+$, $Cl^-$) and CK levels during episodes. Thyroid function tests are mandatory to exclude thyrotoxic periodic paralysis.

• Cardiac Monitoring: ECG to screen for Long QT (Andersen-Tawil Syndrome) and 24-hour Holter monitoring if arrhythmias are suspected.

Genetic Diagnosis at the “Centro Dino Ferrari”

Our center employs a systematic and advanced molecular diagnostic pathway:

• Targeted Approach: Phenotype-driven analysis (e.g., CACNA1S for HypoPP, CLCN1 for myotonia).

• Next-Generation Sequencing (NGS): We utilize Clinical Exome sequencing with a simultaneous analysis of all primary genes involved in muscle channelopathies via a virtual panel.

• Validation: Variant validation in index patients and familial segregation studies are performed using direct (Sanger) sequencing.